dw a 2114r has been researched along with Leukemia L 1210 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akamatsu, K; Endo, K; Kamisango, K; Koizumi, K; Koizumi, M; Matsumoto, T; Morikawa, K | 1 |
| Akamatsu, K; Endoh, K; Kamisango, K; Koizumi, K; Koizumi, M; Matsumoto, T; Matsuno, T; Mitsui, H; Morikawa, K | 1 |
| Akamatsu, K; Endo, K; Kamisango, K; Koizumi, K; Koizumi, M; Matsumoto, T; Matsuno, T; Mitsui, H; Morikawa, K | 1 |
3 other study(ies) available for dw a 2114r and Leukemia L 1210
| Article | Year |
|---|---|
Potent antitumour activity of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) against advanced L1210 leukaemia in mice.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Cycle; Cell Division; Immunity, Cellular; Leukemia L1210; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Neoplasm Transplantation; T-Lymphocytes; Time Factors | 1992 |
Comparison of the antitumour effects and nephrotoxicity-inducing activities of two new platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)-platinum (II) monohydrate, and its enantiomeric isomer.
Topics: Animals; Antineoplastic Agents; Blood Urea Nitrogen; Carboplatin; Isomerism; Kidney; Leukemia L1210; Male; Mice; Mice, Inbred DBA; Mice, Inbred Strains; Tissue Distribution | 1991 |
[Antitumor activity of a new platinum complex, (R)-(-)-2-aminomethylpyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II), against cisdiamminedichloroplatinum (II)-resistant murine leukemia cell line].
Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Line; Cisplatin; Drug Evaluation, Preclinical; Drug Resistance; In Vitro Techniques; Leukemia L1210; Mice; Neoplasm Transplantation; Organoplatinum Compounds | 1990 |